XML 33 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash flows from operating activities:    
Net income $ 97,117 $ 86,628
Adjustments to reconcile net income to net cash provided by operating activities:    
Tax benefit from the exercise of options (4,278) (4,298)
Depreciation and amortization 9,688 9,104
Loss on disposal of fixed assets 885 175
Other Asset Impairment Charges 0 6,955
Deferred Income Tax Expense (Benefit) (572) 0
Stock-based compensation 15,236 12,660
Accrued interest on note receivable – related party 0 529
Deferred rent expense 1,420 1,264
Realized gain on sale of marketable securities (136) (2,029)
Changes in:    
Accounts receivable, net of allowances (2,243) 6,171
Due from factor, net of allowances (79,762) (95,325)
Inventories (35,985) (22,180)
Prepaid expenses, deposits and other assets (3,094) (5,792)
Accounts payable and other accrued expenses 59,813 20,896
Net cash provided by operating activities 58,089 14,758
Cash flows from investing activities:    
Purchases of property and equipment (16,366) (15,617)
Purchases of marketable securities (50,548) (48,955)
Advance to seller of SM Canada 0 (3,085)
Payment of contingent liability (6,952) (7,076)
Sale of marketable securities 30,146 40,150
Acquisitions, net of cash acquired 0 (29,367)
Net cash used for investing activities (43,720) (63,950)
Cash flows from financing activities:    
Common stock share repurchases for treasury (69,465) 0
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders (468) 0
Proceeds from exercise of stock options 4,935 6,991
Tax benefit from the exercise of stock options 4,278 4,298
Net cash (used for)/provided by financing activities (60,720) 11,289
Net decrease in cash and cash equivalents (46,351) (37,903)
Cash and cash equivalents – beginning of period 168,777  
Cash and cash equivalents – end of period $ 122,426 $ 64,927